Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Man detained for storing and selling banned Avil,Omgesic, Spasmo Proxivon, Lomotil

      Man detained for storing and selling banned Avil,Omgesic, Spasmo Proxivon, Lomotil

      Ruby Khatun Khatun9 Jun 2018 10:30 AM IST
      MOHALI: Mohali police recently detained a huge amount of banned medicines from a house in Phase VII and arrested a man but his partner in crime fled...
      Fullerton launches mobile healthcare van in Villuppuram dist

      Fullerton launches mobile healthcare van in Villuppuram dist

      Ruby Khatun Khatun9 Jun 2018 10:15 AM IST
      Chennai: NBFC firm Fullerton India Credit Company Limited on Thursday launched a mobile healthcare van in Villuppuram district of Tamil Nadu.The...
      AbbVies rheumatoid arthritis drug succeeds in late-stage study

      AbbVie's rheumatoid arthritis drug succeeds in late-stage study

      Ruby Khatun Khatun9 Jun 2018 10:00 AM IST
      Abbvie Inc said its experimental drug met the main goal of halting the progression of moderate-to-severe rheumatoid arthritis in a late-stage...
      Roche drugs show limited benefit in lung, breast cancer trials

      Roche drugs show limited benefit in lung, breast cancer trials

      Ruby Khatun Khatun9 Jun 2018 9:30 AM IST
      CHICAGO: In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung cancer...
      Seven Hills Hospital: Nita Ambani-led Reliance Foundation submits bid for takeover

      Seven Hills Hospital: Nita Ambani-led Reliance Foundation submits bid for takeover

      Ruby Khatun Khatun8 Jun 2018 5:06 PM IST
      Mumbai: In order to acquire the troubled Seven Hills Hospital, Nita Ambani-led Reliance Foundation has joined the race and submitted its bid for...
      Glenmark gets USFDA approval for contraceptive drugs

      Glenmark gets USFDA approval for contraceptive drugs

      Ruby Khatun Khatun8 Jun 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic versions of Loestrin tablets, used to prevent...
      Call for Submissions Open for the Sixth HIMSS-Elsevier Digital Healthcare Award in Asia Pacific

      Call for Submissions Open for the Sixth HIMSS-Elsevier Digital Healthcare Award in Asia Pacific

      Ruby Khatun Khatun8 Jun 2018 10:15 AM IST
      Singapore: HIMSS Asia Pacific and Elsevier, the global information analytics company specializing in science and health, are proud to announce the...
      Roche gets priority review from FDA for Hemlibra

      Roche gets priority review from FDA for Hemlibra

      Ruby Khatun Khatun8 Jun 2018 10:00 AM IST
      ZURICH: Roche has been given fast-track review by the U.S. Food and Drug Administration (FDA) for its Hemlibra treatment for people with a form of...
      Mercks Keytruda shows promise in treating advanced melanoma

      Merck's Keytruda shows promise in treating advanced melanoma

      Ruby Khatun Khatun8 Jun 2018 9:45 AM IST
      Merck & Co Inc said long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma patients, a day after...
      EMA issues measures to minimize liver damage risk from Richters Esmya

      EMA issues measures to minimize liver damage risk from Richter's Esmya

      Ruby Khatun Khatun8 Jun 2018 9:30 AM IST
      European Medicines Agency (EMA) issued guidelines to help minimize the risk of rare but serious liver injury associated with Hungarian drugmaker...
      NPPA to undergo Restructuring

      NPPA to undergo Restructuring

      Ruby Khatun Khatun7 Jun 2018 5:37 PM IST
      NPPA to see a shift in its role from Price Fixer to mere RegulatorNew Delhi: Soon the country will be going to have a new form of National...
      Sahajanand Medical Technologies to start S-Flex Registry in Netherlands

      Sahajanand Medical Technologies to start S-Flex Registry in Netherlands

      Ruby Khatun Khatun7 Jun 2018 10:45 AM IST
      Mumbai / Netherlands: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, announced the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok